A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.
Crimean-Congo Haemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15-70% of reported cases are fatal. There is no approved vaccine available, and preclinical protection in vivo by an experimental vaccine has...
Main Authors: | Karen R Buttigieg, Stuart D Dowall, Stephen Findlay-Wilson, Aleksandra Miloszewska, Emma Rayner, Roger Hewson, Miles W Carroll |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24621656/pdf/?tool=EBI |
Similar Items
-
Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses.
by: Stuart D Dowall, et al.
Published: (2016-01-01) -
Crimean-Congo Haemorrhagic Fever
by: Hürrem BODUR
Published: (2009-03-01) -
Absence of Crimean-Congo haemorrhagic fever virus in the tick Hyalomma aegyptium parasitizing the spur-thighed tortoise (Testudo graeca) in Tunisia
by: Fares Wasfi, et al.
Published: (2019-01-01) -
Crimean-Congo haemorrhagic fever virus in Kazakhstan (1948-2013)
by: Talgat Nurmakhanov, et al.
Published: (2015-09-01) -
Crimean-Congo haemorrhagic fever outcome forecasting
by: N. Pshenichnaya, et al.
Published: (2020-12-01)